1. Home
  2. CORT vs PRI Comparison

CORT vs PRI Comparison

Compare CORT & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • PRI
  • Stock Information
  • Founded
  • CORT 1998
  • PRI 1927
  • Country
  • CORT United States
  • PRI United States
  • Employees
  • CORT N/A
  • PRI N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • PRI Life Insurance
  • Sector
  • CORT Health Care
  • PRI Finance
  • Exchange
  • CORT Nasdaq
  • PRI Nasdaq
  • Market Cap
  • CORT 7.6B
  • PRI 8.6B
  • IPO Year
  • CORT N/A
  • PRI N/A
  • Fundamental
  • Price
  • CORT $70.86
  • PRI $260.00
  • Analyst Decision
  • CORT Strong Buy
  • PRI Buy
  • Analyst Count
  • CORT 4
  • PRI 7
  • Target Price
  • CORT $139.00
  • PRI $316.00
  • AVG Volume (30 Days)
  • CORT 938.9K
  • PRI 143.3K
  • Earning Date
  • CORT 11-04-2025
  • PRI 11-05-2025
  • Dividend Yield
  • CORT N/A
  • PRI 1.60%
  • EPS Growth
  • CORT N/A
  • PRI 61.36
  • EPS
  • CORT 1.11
  • PRI 20.26
  • Revenue
  • CORT $716,080,000.00
  • PRI $3,220,913,000.00
  • Revenue This Year
  • CORT $28.85
  • PRI $4.38
  • Revenue Next Year
  • CORT $34.98
  • PRI $5.41
  • P/E Ratio
  • CORT $63.79
  • PRI $12.83
  • Revenue Growth
  • CORT 25.71
  • PRI 7.56
  • 52 Week Low
  • CORT $47.63
  • PRI $230.98
  • 52 Week High
  • CORT $117.33
  • PRI $307.91
  • Technical
  • Relative Strength Index (RSI)
  • CORT 38.04
  • PRI 40.11
  • Support Level
  • CORT $70.89
  • PRI $255.12
  • Resistance Level
  • CORT $74.25
  • PRI $266.12
  • Average True Range (ATR)
  • CORT 2.71
  • PRI 5.80
  • MACD
  • CORT -0.46
  • PRI -0.41
  • Stochastic Oscillator
  • CORT 11.12
  • PRI 25.85

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

Share on Social Networks: